These findings establish a novel ceRNA mechanism wherein geniposide modulates astrocyte survival via Six3os1‐dependent regulation of miR‐511‐3p and MAPK/NLRP3 signaling, offering therapeutic insights for depression. This evidence concerns the gene NLRP3 and major depressive disorder.